NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
08/29/2018
Back to search
Official data from USPTO
GENECURE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
33
Latest update
08/29/2018
Trademark type
Word
Nice classes
5
Filing date
08/10/2007
Registration date
08/26/2008
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/29/2018
Last transaction
08/29/2018
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
First use anywhere
09/30/1998
First use in commerce
01/01/1999
Drawing code
4
Owner type
01
Owner location
Duluth, GA
Examiner
MCCAULEY, BRENDAN
Law office
M50
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
Tung, Frank
Representatives
Tung, Frank
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations for the prevention and treatment of disorders of the nervous systemthe immune systemthe cardio-vascular systemthe metabolic systemthe respiratory systemthe musculo-skeletal systemthe genitourinary system; for the treatment of inflammatory disorders; for use in dermatologyoncologyhematology and in tissue and organ transplantationin ophthalmology and for gastroenterological disorders; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases; for the treatment of bacteria-based diseases; for the treatment of diabetesanti-infective preparationsantiviral preparationsantibioticsantifungal preparations and vaccines; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical products for the treatment of viral and infectious diseasesfor the treatment of cancer; Pharmaceuticalsanti-infectives
Publications
History of USPTO decisions and trademark events.
33 publications found
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
08/29/2018
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
08/29/2018
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
08/29/2018
E89R
TEAS SECTION 8 & 9 RECEIVED
08/20/2018
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
08/20/2018
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
08/26/2017
NAS8
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
12/09/2013
8.OK
REGISTERED - SEC. 8 (6-YR) ACCEPTED
12/09/2013
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
12/09/2013
8.AF
REGISTERED - SEC. 8 (6-YR) FILED
12/02/2013
ES8R
TEAS SECTION 8 RECEIVED
12/02/2013
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
12/02/2013
R.PR
REGISTERED-PRINCIPAL REGISTER
08/26/2008
PUBO
PUBLISHED FOR OPPOSITION
06/10/2008
NPUB
NOTICE OF PUBLICATION
05/21/2008
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
05/05/2008
ALIE
ASSIGNED TO LIE
05/05/2008
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/05/2008
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/02/2008
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/01/2008
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/01/2008
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
01/11/2008
GNRT
NON-FINAL ACTION E-MAILED
01/11/2008
CNRT
NON-FINAL ACTION WRITTEN
01/11/2008
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/10/2008
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/08/2008
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/08/2008
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
11/19/2007
GNRT
NON-FINAL ACTION E-MAILED
11/19/2007
CNRT
NON-FINAL ACTION WRITTEN
11/19/2007
DOCK
ASSIGNED TO EXAMINER
11/16/2007
NWAP
NEW APPLICATION ENTERED
08/15/2007
Continuous trademark protection
Get notified about every new filing that threatens GENECURE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.